Search clinical trials for: Ioforminol 160 mgI/mL
Total 0 results
Nothing found
Sponsors and Collaborators
- Sahachat Aueyingsak
- Sublimity Therapeutics Holdco Limited
- the people hospital of Linzhi
- National Institute of Cardiovascular Diseases, Bangladesh
- Åke Wibergs Stiftelse
- Bassam Abdulkarim
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- Glasgow Western Infirmary
- Dr Philippe METELLUS
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- Etan Orgel
- Daniela Pacella - University of Naples Federico II, Naples
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- Hospitales Universitarios Virgen del Rocío
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- ECMC
- AlpinARC
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- Centro Universitário Franciscano
- View Full List
Medical Conditions
- Ability to Swim 100m Independent Freestyle
- Hyperprolinemia
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Patients With Leptomeningeal Disease
- Transitional Cell Carcinoma of Renal Pelvis
- Panniculectomy
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Progression to PD-1 Antibody
- Legal History
- Value-Based Health Insurance
- Eosinophil Blood Count
- Initiation of Depo-Provera (DMPA)
- Genetic Risk Factor
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Pancreaticoduodenectomy
- Orthopaedic Disorders
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- Interviews
- Degenerative Spondylolisthesis G1
- View Full List
Drug Interventions
- Omeprazole 20mg
- 0% N2O
- Gefitinib
- Paliperidone palmitate
- Prasugrel
- Nimotuzumab
- Erythropoietin
- HBM4003 and Triprilimab
- Cefuroxime 750mg oral
- UFUR and Iressa
- Metoclopramide + dexamethasone
- Antibiotic treatment
- 6% hetastarch
- Injectable Insulin
- Epirubicin hydrochloride
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- IV rtPA (intravenous recombinant plasminogen activator)
- 5-Fluoro-uracil
- ASP8062
- Mepivacaine
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Chile
- Contract Research Organizations in China
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Liberia
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Uganda
- Contract Research Organizations in United Arab Emirates
- CRO list by country